Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-09-003692
Filing Date
2009-02-27
Accepted
2009-02-27 16:52:25
Documents
21
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K y74834e10vk.htm 10-K 1482413
2 EX-3.2: SECOND AMENDED AND RESTATED BYLAWS y74834exv3w2.htm EX-3.2 79561
3 EX-10.12: FORM OF NON-QUALIFED STOCK OPTION AGREEMENT y74834exv10w12.htm EX-10.12 18697
4 EX-10.13: FORM OF NON-QUALIFIED STOCK OPTION AGREEMENT y74834exv10w13.htm EX-10.13 23475
5 EX-10.20: FORM OF RESTRICTED STOCK UNIT AGREEMENT y74834exv10w20.htm EX-10.20 13446
6 EX-10.38: AMENDMENT TO LETTER AGREEMENT y74834exv10w38.htm EX-10.38 8622
7 EX-10.41: AMENDMENT TO CHANGE OF CONTROL ARRANGEMENT y74834exv10w41.htm EX-10.41 7643
8 EX-10.43: AMENDMENT TO AMENDED AND RESTATED EMPLOYMENT AGREEMENT y74834exv10w43.htm EX-10.43 7730
9 EX-10.46: AMENDMENT TO EMPLOYMENT AGREEMENT y74834exv10w46.htm EX-10.46 7675
10 EX-10.49: AMENDMENT TO EMPLOYMENT AGREEMENT y74834exv10w49.htm EX-10.49 7676
11 EX-10.51: AMENDMENT TO CHANGE IN CONTROL ARRANGEMENT y74834exv10w51.htm EX-10.51 7564
12 EX-10.57: SCIENTIFIC ADVISORY BOARD AND CONSULTING AGREEMENT y74834exv10w57.htm EX-10.57 30325
13 EX-10.62: COMPENSATORY ARRANGEMENTS y74834exv10w62.htm EX-10.62 10460
14 EX-10.63: COMPENSATORY ARRANGEMENTS y74834exv10w63.htm EX-10.63 16560
15 EX-21: SUBSIDIARIES y74834exv21.htm EX-21 998
16 EX-23: CONSENT OF KPMG LLP y74834exv23.htm EX-23 1922
17 EX-31.1: CERTIFICATION y74834exv31w1.htm EX-31.1 6452
18 EX-31.2: CERTIFICATION y74834exv31w2.htm EX-31.2 6953
19 EX-32.1: CERTIFICATION y74834exv32w1.htm EX-32.1 3264
20 EX-32.2: CERTIFICATION y74834exv32w2.htm EX-32.2 3841
21 GRAPHIC y74834y7483400.gif GRAPHIC 6463
  Complete submission text file 0000950123-09-003692.txt   1755824
Mailing Address 41 PINELAWN ROAD MELVILLE NY 11747
Business Address 41 PINELAWN ROAD MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-15190 | Film No.: 09643843
SIC: 2835 In Vitro & In Vivo Diagnostic Substances